Use of solanum lycopersicum extract for alleviating eye dryness discomfort and improving visual functions
The composition prepared by using black tomato extract solves the problems of dry eyes and blurred vision caused by prolonged use of electronic products by modern people, significantly improves vision and visual function, and enhances visual clarity and comfort.
Patent Information
- Application Number
- PCT/CN2025/141783
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-12
- Filing Date
- 2025-12-11
- Publication Date
- 2026-11-19
AI Technical Summary
Modern people's prolonged use of electronic products leads to problems such as dry eyes, soreness, and blurred vision. Existing relief methods still have room for improvement in terms of relief speed, lasting effect, and ease of use, and it is difficult to simultaneously take into account visual care and the comfort of daily use.
Compositions containing black tomato extract are prepared by using black tomato extract to relieve dry and uncomfortable eyes and improve visual function, including improving visual acuity, eye accommodation, visual contrast sensitivity and retinal light adaptation.
Black tomato extract significantly relieves dry and uncomfortable eyes, improves vision and visual function, especially vision and contrast sensitivity in different environments and at different distances, and enhances individual visual clarity and comfort.
Smart Images

Figure CN2025141783_19112026_PF_FP_ABST
Abstract
Description
Uses of black tomato extract to relieve dry and uncomfortable eyes and improve visual function Technical Field
[0001] This invention relates to a black tomato extract, and more particularly to a black tomato extract and its uses. Background Technology
[0002] Modern people spend long hours using electronic products such as computers, smartphones, and tablets, leading to a significant increase in the amount of time spent on close-range visual tasks. The blue light emitted from screens, prolonged focus on a fixed focal length, and lack of adequate rest often cause dry eyes, soreness, blurred vision, and eye fatigue.
[0003] With changes in work and leisure patterns, eye strain has become a common health problem. Current technologies mostly help relax the eyes by adjusting the lighting environment, using blue light filtering lenses, or applying heat and massage, but there is still room for improvement in terms of the speed of relaxation, the duration of effect, and the ease of use.
[0004] In addition, some methods fail to simultaneously address both visual maintenance and the comfort of daily use, making it challenging to maintain good visual condition in the long term.
[0005] Invention disclosure
[0006] In some embodiments, a black tomato extract is used to prepare a composition for relieving dry and uncomfortable eyes in an individual, wherein the composition includes a black tomato extract obtained from a black tomato (Solanum lycopersicum).
[0007] In some embodiments, the aforementioned dry and uncomfortable eyes are eye pain, photophobia, blurred vision, foreign body sensation in the eye, or a combination thereof.
[0008] In some embodiments, a black tomato extract is used to prepare a composition for improving an individual's visual function, wherein the composition includes a black tomato extract obtained from a black tomato (Solanum lycopersicum).
[0009] In some embodiments, the aforementioned improvement of an individual's visual function is to enhance the individual's visual acuity, eye accommodation, visual contrast sensitivity, retinal light adaptation, or a combination thereof.
[0010] In some embodiments, the aforementioned improvement of an individual's vision refers to improvement of near vision.
[0011] In some embodiments, the aforementioned improvement of an individual's vision refers to improvement of distance vision.
[0012] In some embodiments, the aforementioned improvement of an individual's accommodative power refers to enhancing the individual's ability to contract and relax the ciliary muscle.
[0013] In some embodiments, the aforementioned improvement of an individual's visual contrast sensitivity refers to improving visual contrast sensitivity in dimly lit environments.
[0014] As can be seen from the above, the black tomato extract of any embodiment has a variety of functions to improve eye function: the black tomato extract has the ability to relieve eye soreness, photophobia, blurred vision, foreign body sensation in the eye and other dry and uncomfortable conditions, and has the ability to improve an individual's visual function, such as visual acuity, eye accommodation, visual contrast sensitivity and retinal light adaptation.
[0015] Brief description of the attached figures
[0016] Figure 1 shows the results of near vision tests conducted on subjects in a bright environment at weeks 0, 4, and 8.
[0017] Figure 2 shows the relative results of near vision tests conducted on subjects in a bright environment at weeks 0, 4, and 8.
[0018] Figure 3 shows the proportion of control group subjects whose near vision in a bright environment improved (marked as "improvement") or did not improve (marked as "maintain") compared to week 0 at weeks 4 and 8.
[0019] Figure 4 shows the proportion of subjects in the experimental group whose near vision in a bright environment improved (marked as "improvement") or did not improve (marked as "maintain") compared to week 0 at weeks 4 and 8.
[0020] Figure 5 shows the results of near vision tests conducted on subjects in dim lighting conditions during weeks 0, 4, and 8.
[0021] Figure 6 shows the relative results of near vision tested in dim light at weeks 0, 4, and 8.
[0022] Figure 7 shows the proportion of control group subjects whose near vision in dim light improved (marked as "improvement") or did not improve (marked as "maintain") compared to week 0 at weeks 4 and 8.
[0023] Figure 8 shows the proportion of subjects in the experimental group whose near vision in dim light improved (marked as "improvement") or did not improve (marked as "maintain") compared to week 0 at weeks 4 and 8.
[0024] Figure 9 shows the results of distance vision tests conducted on subjects in dim lighting conditions during weeks 0, 4, and 8.
[0025] Figure 10 shows the relative results of distance visual acuity of the subjects in dim light at weeks 0, 4, and 8.
[0026] Figure 11 shows the proportion of subjects in the control group whose distance vision in dim light improved (marked as "improvement") or did not improve (marked as "maintain") compared to week 0 at weeks 4 and 8.
[0027] Figure 12 shows the proportion of subjects in the experimental group whose distance vision in dim light improved (marked as "improvement") or did not improve (marked as "maintain") compared to week 0 at weeks 4 and 8.
[0028] Figure 13 shows the data results of the subjects' visual contrast sensitivity in dim environments and at a distance during weeks 0, 4, and 8.
[0029] Figure 14 shows the relative results of the subjects' visual contrast sensitivity in dim environments and at a distance during weeks 0, 4, and 8.
[0030] Figure 15 shows the proportion of subjects in the control group with different visual contrast sensitivity (i.e., good contrast sensitivity, insufficient contrast sensitivity, and poor contrast sensitivity) in dim environments and at long distances during weeks 0, 4, and 8.
[0031] Figure 16 shows the proportion of subjects in the experimental group with different visual contrast sensitivity (i.e., good contrast sensitivity, insufficient contrast sensitivity, and poor contrast sensitivity) in dim environments and at long distances during weeks 0, 4, and 8.
[0032] Figure 17 shows the data results of the subjects' binocular accommodation at weeks 0, 4, and 8.
[0033] Figure 18 shows the relative results of binocular accommodation in subjects at weeks 0, 4, and 8; and
[0034] Figure 19 shows the severity of dry eye-related symptoms in the experimental group subjects at weeks 0, 4, and 8.
[0035] Best way to implement the present invention
[0036] In this document, the term "extract" refers to a product prepared by extraction. Extracts may be presented in the form of a solution dissolved in a solvent, or as a concentrate or essence containing little or no solvent, or as a dried powder.
[0037] Black tomatoes (Solanum lycopersicum) are a special variety developed in recent years. Their deep purple to black appearance is due to the abundance of anthocyanins in their peel. Black tomatoes possess both anthocyanins and lycopene, two types of phytochemicals, exhibiting broad-spectrum antioxidant properties that effectively scavenge free radicals and reduce oxidative stress.
[0038] In some embodiments, the raw material for the black tomato extract is black tomato fruit, and the black tomato extract is obtained by processing the black tomato fruit through at least one step, such as chopping, extraction, filtration, concentration, and drying. Here, the black tomato fruit can be washed and dried, and can be selectively subjected to crushing, cutting, coarse crushing (e.g., cutting into 12mm sizes), grinding, or other processing steps to obtain a raw material suitable for the extraction process.
[0039] In some embodiments, black tomato fruit is extracted with an extraction solution at a specific temperature for a period of time to obtain a crude black tomato extract. The extraction solution is selected from water, an acidic solution, an enzyme solution, or an enzyme-containing acidic solution. Furthermore, there is no particular limitation on the amount of extraction solution used, as long as it sufficiently and uniformly disperses the raw material (e.g., black tomato fruit) therein. For example, the volume ratio of the extraction solution to black tomatoes is 1-20:1 (e.g., 5:1).
[0040] In some embodiments, the aforementioned acidic solution is a solution composed of water and one or more acidic components. For example, the acidic component may be acetic acid, citric acid, hydrochloric acid, or a combination thereof. In some embodiments, the weight ratio of the acidic component to water is 0.1-5:100. For example, the acidic component may be citric acid, and the acidic solution is a mixture of citric acid and water at a weight ratio of 0.5-5:100. For example, the acidic solution may be an aqueous solution containing 1% by weight of citric acid.
[0041] In some embodiments, the aforementioned enzyme solution is an aqueous solution containing one or more cellulases. For example, the cellulase includes endo-beta-glucanase (also known as endo-β-glucanase), which can hydrolyze the (1,3)- or (1,4)-glycosidic bonds in β-D-glucan. For example, the cellulase can be a compound cellulase composed of water, sucrose, sodium chloride, endo-β-glucanase (endo-1,3(4)-bonds), potassium sorbate, etc., and the acidic solution is prepared by mixing the compound cellulase and water at a weight ratio of 0.1:100. For example, the acidic solution can be an aqueous solution containing 0.1% by weight of the compound cellulase.
[0042] In some embodiments, the enzyme-containing acidic solution is an aqueous solution containing one or more acidic components and one or more cellulases. The types of acidic components and cellulases are as described above and will not be repeated here. For example, the extraction solution is an enzyme-containing acidic solution containing 1% by weight citric acid and 0.1% by weight compound cellulase (composed of multiple cellulases).
[0043] In some embodiments, the aforementioned "specific temperature" for extraction can be 35°C to 45°C (e.g., 40±3°C). In some embodiments, the aforementioned "time period" required for extraction is at least 0.5 hours. For example, the "time period" required for extraction is 0.5 hours to 2 hours. In some embodiments, black tomatoes are added and extraction is performed for a period of time only after the extraction solution has been heated to this specific temperature. Here, because black tomatoes contain heat-sensitive substances, low-temperature extraction is necessary.
[0044] In some embodiments, the aforementioned crude black tomato extract is filtered through a 400-mesh filter to remove solids and obtain black tomato filtrate.
[0045] In some embodiments, the aforementioned black tomato filtrate is concentrated under reduced pressure to obtain a black tomato extract. Here, the temperature conditions for reduced pressure concentration are between 45°C and 70°C (e.g., 55±5°C).
[0046] In some embodiments, the aforementioned black tomato extract is processed by a drying process to obtain black tomato extract powder. This drying process can be performed by methods such as freeze drying or spray drying. For example, the black tomato extract is mixed with maltodextrin in a specific ratio and then spray-dried to obtain solid black tomato extract powder.
[0047] Therefore, both the aforementioned black tomato extract liquid and black tomato extract powder belong to the category of "black tomato extract" in this article. The only difference between the two is the morphology of the substance, and there is no significant difference in the composition of active ingredients.
[0048] Unless otherwise stated herein, the term "improvement / alleviation" as used herein refers to the optimization or enhancement of a normal or suboptimal physiological state; "regulation" refers to positive regulation (including induction, stimulation, enhancement, and strengthening) or negative regulation (including inhibition, reduction, decrease, and weakening) to bring an individual toward a normal state of said physiological function; "individual" refers to a mammal, which may be human or non-human animal; "receptor" refers to the object of action of the extracts, compositions, methods, or uses of this application. Receptors may include, but are not limited to, humans, other mammals, animal models, and samples from cell, tissue, or other biological sources. Unless otherwise expressly defined, the term "receptor" as used herein is not limited to a specific species or state, and may also encompass in vivo or in vitro test subjects.
[0049] In some embodiments, black tomato extract alleviates dry and uncomfortable eyes by reducing eye strain, relieving photophobia, improving blurred vision, and reducing the sensation of a foreign body in the eye. In other words, consuming black tomato extract can improve vision and increase eye comfort, thereby achieving the aforementioned functions.
[0050] In some embodiments, black tomato extract improves an individual's visual function by enhancing visual acuity, accommodative power, visual contrast sensitivity, and retinal light adaptation. Enhancing visual acuity includes improving near and far vision in different environments (e.g., bright and dim environments); improving visual contrast sensitivity includes improving visual contrast sensitivity in different environments (e.g., bright and dim environments) and at different distances (e.g., far distance); improving accommodative power includes enhancing the ciliary muscle's ability to contract and relax; and improving retinal light adaptation includes improving near / far vision in different environments (e.g., bright and dim environments) and enhancing adaptability to external brightness stimuli.
[0051] For example, individuals who take black tomato extract may experience improved visual acuity and reduced eye fatigue caused by blurred vision, thus improving efficiency in close-range reading and computer work. Individuals who spend long periods of time using their eyes at close range (such as students and office workers) may experience reduced eye fatigue and decreased likelihood of blurred vision after taking black tomato extract. Or / and, individuals who take black tomato extract may experience improved accuracy in fine motor skills in dim environments and improved nighttime visual acuity, meeting the visual needs of nighttime activities (e.g., making it easier to see the trajectory of a baseball in a nighttime baseball game) and the needs of those working in darkrooms (e.g., darkroom operators, X-ray operators, astronomers, film projectionists, etc.). Or / and, individuals who take black tomato extract may experience improved nighttime visual acuity and reduced glare from streetlights and vehicle headlights in dim environments, thus improving visibility of pedestrians and vehicles on dimly lit streets and enhancing driving safety (e.g., recognizing the road surface in dim environments to avoid falls and improving the safety of nighttime driving).
[0052] In some embodiments, the aforementioned term "close distance" means that the distance between the individual and the observed object is no greater than 40 centimeters (e.g., 40 centimeters). In some embodiments, the aforementioned term "far distance" means that the distance between the individual and the observed object is no less than 6 meters (e.g., 6 meters).
[0053] In some embodiments, the aforementioned term "bright environment" refers to an environment in which the individual is located with an illuminance of approximately 300 lux to 1000 lux (e.g., 1000 lux). In some embodiments, the aforementioned term "dim environment" refers to an environment in which the individual is located with an illuminance of approximately 1 lux to 50 lux (e.g., 25 lux).
[0054] In some embodiments, any of the foregoing compositions may be a non-medicinal edible product. In other words, the edible product contains a specific amount of black tomato extract. In some embodiments, the edible product may be a general food, a health food, or a dietary supplement.
[0055] In some embodiments, the aforementioned edible products may be manufactured into dosage forms suitable for oral administration using techniques well known to those skilled in the art. In some embodiments, the aforementioned general food may be the edible product itself. In some embodiments, general food may be, but is not limited to, beverages, fermented foods, bakery products, or seasonings.
[0056] In some embodiments, the obtained black tomato extract can be further used as a food additive to prepare a food composition containing the black tomato extract. Thus, the black tomato extract of any embodiment can be added during the preparation of raw materials or during the food production process using existing methods, and can be formulated with any edible material to create an edible product (i.e., a food composition) for human and non-human animal consumption.
[0057] In some embodiments, the aforementioned composition containing black tomato extract may contain black tomato extract in a liquid or solid form. For example, the solid form may be powder or tablets.
[0058] In some embodiments, the composition is used in an amount of 0.8 g / day of solid black tomato extract (e.g., black tomato extract powder).
[0059] Example 1: Preparation method of black tomato extract
[0060] Example 1-1: Preparation method of liquid black tomato extract (i.e., black tomato extract liquid)
[0061] First, the black tomatoes (origin: Gaotai County, Zhangye City, Gansu Province) were coarsely crushed into 12 mm pieces (i.e., black tomato pieces), and a compound fiber enzyme containing 0.1% by weight (purchased from Novozymes, product: ...) was prepared. The extraction solution consisted of an acidic solution containing enzymes, including endo-β-glucanase and 1% by weight citric acid (manufacturer: Weifang Yingxuan Industrial Co., Ltd.). The concentrations of the compound enzymes and citric acid were calculated based on the volume of the extraction solution (i.e., the amount added during the black tomato extract production process), and the weight ratio of the extraction solution to the black tomato pieces was 5:1. Next, the extraction solution was heated to 40℃±3℃, and the black tomato pieces were added. The reflux pump operating pressure was set to 3.0±0.5 kg / cm³. 2 Extract at a stable flow rate for 30 minutes to obtain crude extract of black tomatoes.
[0062] Next, the aforementioned crude black tomato extract was filtered through a 400-mesh sieve to obtain black tomato filtrate. The soluble solids content (Brix) of the black tomato filtrate at 20°C was approximately 1.4 ± 0.3.
[0063] Then, the black tomato filtrate was concentrated under reduced pressure at 40℃±5℃ using a concentrator (brand: Yuancheng Machinery Co., Ltd., model YC-VC-500). The concentrated black tomato filtrate was then filtered a second time through a 400-mesh filter to obtain "black tomato extract". The soluble solids content (Brix) of this black tomato extract at 20℃ is approximately 10.0±0.3%.
[0064] Example 1-2: Preparation method of solid black tomato extract (i.e., black tomato extract powder)
[0065] The black tomato extract obtained in Example 1-1 above was used to prepare black tomato extract powder.
[0066] The soluble solids in the black tomato extract prepared in Example 1-1 were tested to ensure that each 100 grams of black tomato extract contained approximately 10 grams of soluble solids, and maltodextrin was added. Therefore, the weight ratio of soluble solids to maltodextrin was 1:2.
[0067] The mixture of the aforementioned soluble solids and maltodextrin was spray-dried and sieved through a 40-mesh filter to obtain "black tomato extract powder".
[0068] Example 2: Human trials
[0069] Therefore, the black tomato extract powder prepared in Examples 1-2 was used to make test samples, with each test sample containing 400 mg of solid black tomato extract. The test dosage was one packet of test sample taken twice daily, in the morning and evening, for a total daily intake of 800 mg of black tomato extract.
[0070] Test sample formulation:
[0071] Each packet contains 400 mg of black tomato extract powder (prepared in Examples 1-2), 1537 mg of isomaltitol, 20 mg of berry flavoring, 3 mg of sucralose, and 40 mg of calcium phosphate.
[0072] Subjects:
[0073] Fifty-six participants were adults aged 20 to 35 with independent behavioral capacity. Furthermore, all participants met the following criteria:
[0074] Visual acuity: Myopia ranging from -5.00 to -9.00 diopters; best corrected visual acuity greater than 0.8. Furthermore, neither patient has undergone any related eye surgeries (such as strabismus surgery, refractive surgery, etc.).
[0075] Physical fitness: Body Mass Index (BMI) between 22 and 35.
[0076] Lifestyle habits: Spending more than 6 hours a day using 3C products.
[0077] Other conditions: None of the subjects had systemic diseases that affect the anterior surface of the eye, and none of them had been taking medications that affect the condition of the anterior surface of the eye for a long period of time.
[0078] Testing method:
[0079] A double-blind, randomized, placebo-controlled trial was conducted. A total of 56 participants were randomly assigned in subsequent experiments: 28 participants were assigned to the placebo group (control group), and 28 participants were assigned to the black tomato extract group (experimental group). Participants took one packet of the test sample or placebo twice daily, morning and evening, for 8 consecutive weeks. Eye-related tests were performed at week 0 (before administration), week 4 (after 4 weeks of administration), and week 8 (after 8 weeks of administration).
[0080] The placebo formulation contains 60 mg of citric acid, 1577 mg of isomaltitol, 20 mg of berry flavoring, 3 mg of sucralose, and 40 mg of calcium phosphate per packet.
[0081] Test items:
[0082] A. Functional visual acuity assessment: long-distance (6 meters away from the subject and the object) and near-distance (40 centimeters away from the subject and the object) tests in bright environments (1000 lux light intensity) and dim environments (25 lux light intensity).
[0083] B. Functional visual contrast sensitivity assessment: Long-distance detection (6 meters away from the subject and the object) in a dim environment (light intensity of 25 lux).
[0084] C. Binocular accommodative power (total accommodative power of the eyes).
[0085] D. Dry eye assessment: Questionnaires were completed in weeks 0, 2, 4, 6 and 8.
[0086] Example 2-1: Functional visual acuity assessment
[0087] Testing method: Snellen chart and reading-based vision test tool.
[0088] Testing Procedure: All subjects participated in vision testing without changing their existing glasses prescription. Distance vision was tested using a wall-mounted Snellen chart at a standard distance of 6 meters; near vision was tested using a reading-type vision test tool at a distance of 40 centimeters. Tests were conducted under two lighting conditions: a bright environment with a light intensity of 1000 lux and a dim environment with a light intensity of 25 lux. The Snellen chart values were converted to LogMAR (logarithm of the Minimum Angle of Resolution) values for analysis. Near vision was represented by a positive LogMAR value; a smaller value (e.g., closer to 0) indicated better vision, and a larger value indicated worse vision. Distance vision was represented by a negative LogMAR value; a smaller value (larger absolute number) indicated better vision, and a larger value indicated worse vision.
[0089] In the functional visual acuity assessment experiment, near and far visual acuity were tested in bright and dim environments, respectively. The results are shown in Figures 1 to 12. In the figures, "*" or "#" represents a p-value less than 0.05. "*" indicates the difference between the experimental group and the control group in the same week (difference between different groups at the same time point); "#" indicates the difference between data from week 8 / week 4 and week 0 (difference between the same group at different time points).
[0090] Near vision in bright environments:
[0091] Please refer to Figures 1 through 4. Referring to Figure 1, at week 0, the mean LogMAR value detected in the experimental group was 0.07, and the mean LogMAR value detected in the control group was 0.05. At week 4, the mean LogMAR values detected in both the experimental and control groups were 0.05. At this point, the value in the experimental group was smaller than that in week 0, while the value in the control group remained essentially unchanged. At week 8, the mean LogMAR value detected in the experimental group was 0.02, a significant decrease compared to week 0 (in Figure 1, "#" indicates a p-value less than 0.05), while the mean LogMAR value detected in the control group was 0.03, which, although also decreasing compared to week 0, was not significantly different. Furthermore, the average LogMAR value measured in week 0 for both the experimental and control groups was considered as 1. Based on this, the fold change in the average LogMAR value measured in weeks 4 and 8 relative to week 0 was calculated. The relative fold for the experimental group was 0.71 in week 4 and 0.36 in week 8, showing a significant decrease in week 8 compared to week 0, as shown in Figure 2. This means that the average LogMAR value of the experimental group gradually decreased with the duration of black tomato extract administration, indicating a significant improvement in near vision in bright environments for the subjects in the experimental group. The relative fold for the control group was 1.02 in week 4 and 0.67 in week 8. This means that the control group experienced a slight decrease in vision after 4 weeks of placebo administration, but there was no significant improvement in vision at week 8 compared to week 0.
[0092] As shown in Figure 3, among the 28 subjects in the control group, the proportion of subjects who felt their near vision improved in bright environments was 21.43% (approximately 6 people) in week 4 and 28.57% (approximately 8 people) in week 8 (see the group labeled "Improvement" in Figure 3). Conversely, the proportion of subjects who felt their vision remained unchanged was 78.57% (approximately 22 people) in week 4 and 71.43% (approximately 20 people) in week 8 (see the group labeled "Maintain" in Figure 3). In other words, after 4 and 8 weeks of continuous placebo administration, there was only a slight difference in the proportion of subjects who reported improvement in near vision in bright environments.
[0093] As shown in Figure 4, among the 28 subjects in the experimental group, the proportion of subjects who felt their near vision improved in bright environments was 25% (approximately 7 people) in week 4 and 42.86% (approximately 12 people) in week 8 (see the group marked "Improvement" in Figure 4). The proportion of subjects who felt their vision remained unchanged was 75% (approximately 21 people) in week 4 and 57.14% (approximately 16 people) in week 8 (see the group marked "Maintain" in Figure 4). After continuous administration of black tomato extract for 4 and 8 weeks, the proportion of subjects experiencing improved near vision in bright environments significantly increased.
[0094] Furthermore, compared to the control group, the percentage of people in the experimental group who reported a significant improvement in near vision in bright environments at week 8 increased by 14.3%.
[0095] Near vision in dim light:
[0096] Please refer to Figures 5 through 8. Referring to Figure 5, at week 0, the mean LogMAR value detected in the experimental group was 0.20, and the mean LogMAR value detected in the control group was 0.19. At week 4, the mean LogMAR value detected in the experimental group was 0.17, while the mean LogMAR value detected in the control group was 0.18. At week 8, the mean LogMAR value detected in the experimental group was 0.15, a significant decrease compared to both the value detected in week 0 and the value detected in the control group at week 8 (Figure 5 shows "#" and "*" indicating p-values less than 0.05), while the mean LogMAR value detected in the control group was 0.19, the same as the value detected in week 0. Furthermore, the mean LogMAR value detected in the experimental and control groups at week 0 was considered as 1, and based on this, the folds of change in the mean LogMAR values detected in weeks 4 and 8 relative to week 0 were calculated. The relative fold increase (RFI) in the experimental group was 0.83 at week 4 and 0.72 at week 8, as shown in Figure 6. This means the mean LogMAR value in the experimental group gradually decreased with the duration of black tomato extract administration, indicating a significant improvement in near vision in dim lighting conditions for the subjects in the experimental group. The RFI in the control group was 0.97 at week 4 and 1.00 at week 8. This means the mean LogMAR value in the control group did not change significantly after 4 or 8 weeks of placebo administration, indicating no improvement in near vision in dim lighting conditions for the control group after 4 or 8 weeks of placebo administration.
[0097] As shown in Figure 7, among the 28 subjects in the control group, the proportion of subjects who felt their near vision improved in dim light was 28.57% (approximately 8 people) in week 4 and 32.14% (approximately 9 people) in week 8 (see the group labeled "Improvement" in Figure 7). Conversely, the proportion of subjects who felt their vision remained unchanged was 71.43% (approximately 20 people) in week 4 and 67.86% (approximately 19 people) in week 8 (see the group labeled "Maintain" in Figure 7). In other words, after 4 and 8 weeks of continuous placebo administration, there was only a slight difference in the proportion of subjects who reported improvement in near vision in dim light.
[0098] As shown in Figure 8, among the 28 subjects in the experimental group, the proportion of subjects who felt their near vision improved in dim lighting was 42.86% (approximately 12 people) in week 4 and 57.14% (approximately 16 people) in week 8 (see the group labeled "Improvement" in Figure 8). The proportion of subjects who felt their vision remained unchanged was also 57.14% (approximately 16 people) in week 4 and 42.86% (approximately 12 people) in week 8 (see the group labeled "Maintain" in Figure 8). After 4 and 8 weeks of continuous use of black tomato extract, the proportion of subjects experiencing improved near vision in dim lighting significantly increased.
[0099] Furthermore, compared to the control group, the percentage of people in the experimental group who reported a significant improvement in near vision in dim lighting at week 8 increased by 25.0%.
[0100] Distance vision in dim light:
[0101] Please refer to Figures 9 through 12. Referring to Figure 9, at week 0, the mean LogMAR value detected in the experimental group was -0.07, and the mean LogMAR value detected in the control group was -0.08. At week 4, the mean LogMAR value detected in the experimental group was -0.11, a significant decrease compared to the value detected at week 0; while the mean LogMAR value detected in the control group was -0.09. At week 8, the mean LogMAR value detected in the experimental group was -0.15, a significant decrease compared to both the value detected at week 0 and the value detected in the control group at week 8 (Figure 9 shows "#" and "*" indicating p-values less than 0.05), while the mean LogMAR value detected in the control group was -0.11. Furthermore, the average LogMAR value measured in week 0 for both the experimental and control groups was considered as 1. Based on this, the fold change in the average LogMAR value measured in weeks 4 and 8 for each group relative to week 0 was calculated. Since distance vision is expressed as a negative logMAR value, a larger proportional increase (i.e., fold) indicates a better improvement. The relative fold for the experimental group was 1.50 in week 4 and 2.02 in week 8, as shown in Figure 10. This means that the average LogMAR value of the experimental group gradually decreased with the duration of black tomato extract administration, while the relative fold increased, indicating a significant improvement in distance vision in dim environments for the subjects in the experimental group. The relative fold for the control group was 1.26 in week 4 and 1.49 in week 8. After 8 weeks of intervention, the experimental group's distance vision test results in dim environments were significantly better than the control group, indicating that black tomato extract can significantly improve distance vision in dim environments compared to a placebo.
[0102] As shown in Figure 11, among the 28 subjects in the control group, the proportion of subjects who felt their distance vision improved in dim light was 32.14% (approximately 9 people) in week 4 and 39.29% (approximately 11 people) in week 8 (see the group labeled "Improvement" in Figure 11). Meanwhile, the proportion of subjects who felt their vision remained unchanged was 67.86% (approximately 19 people) in week 4 and 60.71% (approximately 17 people) in week 8 (see the group labeled "Maintain" in Figure 11). In other words, after 4 and 8 weeks of continuous placebo administration, there was only a slight difference in the proportion of subjects who felt their distance vision improved in dim light.
[0103] As shown in Figure 12, among the 28 subjects in the experimental group, the proportion of subjects who felt their distance vision improved in dim lighting was 39.29% (approximately 11 people) in week 4 and 60.71% (approximately 17 people) in week 8 (see the group labeled "Improvement" in Figure 12). The proportion of subjects who felt their vision remained unchanged was also 60.71% (approximately 17 people) in week 4 and 39.29% (approximately 11 people) in week 8 (see the group labeled "Maintain" in Figure 12). After continuous administration of black tomato extract for 4 and 8 weeks, the proportion of subjects experiencing improved distance vision in dim lighting significantly increased.
[0104] Furthermore, compared to the control group, the percentage of people in the experimental group who reported a significant improvement in their distance vision in dim environments at week 8 increased by 21.42%.
[0105] Therefore, it can be concluded that taking black tomato extract can help improve an individual's vision in different environments and at different distances.
[0106] Example 2-2: Functional visual contrast sensitivity assessment
[0107] Inspection method: Sine-wave grating charts test.
[0108] Testing Procedure: All participants participated in the visual contrast sensitivity test without changing their existing glasses prescription. Contrast sensitivity refers to the ability to distinguish the difference between an object and its background in low-light or blurred environments. This differs from the aforementioned functional visual acuity test (LogMAR visual acuity test), which measures the clarity of the smallest distinguishable font. To assess visual contrast sensitivity at a distance, this experiment used a sine-wave contrast test, conducted in a dim environment (light intensity of 25 lux). During the test, participants viewed sine-wave grating charts, which gradually blurred from highly sharp stripes. Participants were required to observe the point where the stripes could no longer be distinguished, starting from the sharpest area; this point represents the limit of their contrast sensitivity. The measured data were presented as a contrast sensitivity function curve, and the area under the curve (AUC) was further calculated as a quantitative indicator. The larger the area, the better the contrast sensitivity. An AUC value of 30 or more is considered good contrast sensitivity, an AUC value between 20 and 30 is considered insufficient contrast sensitivity, and an AUC value less than 20 is considered poor contrast sensitivity.
[0109] In the experiment on functional visual contrast sensitivity, visual contrast sensitivity was tested in dim environments and at a distance. The results are shown in Figures 13 to 16. In the graphs, "#" represents a p-value less than 0.05. "#" indicates the difference between data from week 8 / week 4 and week 0 (differences within the same group at different time points).
[0110] Please refer to Figures 13 to 16. Referring to Figure 13, at week 0, the mean AUC value detected in the experimental group was 21.07, and the mean AUC value detected in the control group was 20.84. At week 4, the mean AUC value detected in the experimental group was 23.88, a significant improvement compared to the value detected in week 0 (in Figure 13, "#" indicates a p-value less than 0.05); while the mean AUC value detected in the control group was 22.73. At week 8, the mean AUC value detected in the experimental group was 24.53, a significant increase compared to the value detected in week 0 (in Figure 13, "#" indicates a p-value less than 0.05), while the mean AUC value detected in the control group was 23.41. Treating the mean AUC values detected in the experimental and control groups at week 0 as 1, we then calculated the fold change in the mean AUC values detected in weeks 4 and 8 relative to week 0. The relative fold increase in the experimental group was 1.13 at week 4 and 1.16 at week 8, as shown in Figure 14. This means that the mean AUC value in the experimental group gradually increased with the duration of black tomato extract administration, indicating a significant improvement in visual contrast sensitivity in dim environments and at long distances. The relative fold increase in the control group was 1.09 at week 4 and 1.12 at week 8. This means that the mean AUC value in the control group showed a lower change after 4 or 8 weeks of placebo administration, indicating a smaller improvement in visual contrast sensitivity in dim environments and at long distances.
[0111] As shown in Figure 15, among the 28 subjects in the control group, the proportion of subjects who felt good visual contrast sensitivity in dim environments and at a distance was 3.57% (approximately 1 person) in week 0, 7.14% (approximately 2 people) in week 4, and 0% (approximately 0 people) in week 8; the proportion of subjects with insufficient visual contrast sensitivity was 85.71% (approximately 24 people) in week 0, 82.14% (approximately 23 people) in week 4, and 89.29% (approximately 25 people) in week 8; and the proportion of subjects with poor visual contrast sensitivity was 10.71% (approximately 3 people) in week 0, 7.14% (approximately 2 people) in week 4, and 10.71% (approximately 3 people) in week 8. In other words, after taking the placebo for 4 and 8 weeks, the number of subjects with good visual contrast sensitivity in dim environments and at a distance decreased, and most subjects felt that their visual contrast sensitivity was insufficient.
[0112] As shown in Figure 16, among the 28 subjects in the experimental group, the proportion of subjects who felt good visual contrast sensitivity in dim environments and at a distance was 0% (approximately 0 people) in week 0, 10.71% (approximately 3 people) in week 4, and 14.29% (approximately 4 people) in week 8; the proportion of subjects with insufficient visual contrast sensitivity was 92.86% (approximately 26 people) in week 0, 85.71% (approximately 24 people) in week 4, and 85.71% (approximately 24 people) in week 8; and the proportion of subjects with poor visual contrast sensitivity in the control group was 7.14% (approximately 2 people) in week 0, 3.57% (approximately 1 person) in week 4, and 0% (approximately 0 people) in week 8. In other words, after taking black tomato extract for 4 and 8 weeks, the number of subjects with good visual contrast sensitivity in dim environments and at long distances increased, while the number of subjects with poor visual contrast sensitivity decreased to 0.
[0113] Furthermore, compared to the control group, the experimental group showed a 14.29% increase in the number of subjects with good visual contrast sensitivity in dim environments and at long distances by week 8, while a 7.14% decrease in the number of subjects with poor visual contrast sensitivity.
[0114] Example 2-3: Assessment of binocular accommodative power (total accommodative power)
[0115] Test method: Negative relative accommodation (NRA) and positive relative accommodation (PRA) were tested using lenses with a diopter of + / -0.25D.
[0116] Testing Procedure: When the eye switches between viewing near and far objects, the ciliary muscle adjusts the thickness of the lens; this process is called "accommodation." The eye's overall accommodative ability can be assessed using two key indicators: negative relative accommodative power (NRA) and positive relative accommodative power (PRA). NRA assesses the eye's ability to relax accommodation when viewing near objects, while PRA assesses the eye's ability to increase accommodation when focusing. Both measurements are performed by having the subject view a fixed near-field reading target. NRA is measured by gradually adding +0.25D of lens material until the target becomes blurred, representing the limit of their relaxation ability; PRA is measured by gradually adding -0.25D of lens material until the target becomes blurred, representing the limit of their focusing ability. These measurements reflect the eye's accommodative range, and the sum of NRA and PRA represents the ciliary muscle's maximum accommodative capacity. The relative accommodative power can be calculated by the difference between PRA and NRA (NRA value minus PRA value). Among them, relative accommodation can be used to assess the overall eye's ability to relax and contract, and the higher the difference value, the better the overall eye's accommodation ability.
[0117] The results of the binocular accommodation experiment are shown in Figures 17 and 18. In the figures, "#" represents a p-value less than 0.05. "#" indicates the difference between week 8 / week 4 and week 0 (differences within the same group at different time points).
[0118] Please refer to Figures 17 and 18. At week 0, the mean relative regulatory capacity (the difference between PRA and NRA) in the experimental group was 3.55D, and the mean relative regulatory capacity in the control group was 3.51D, with little difference between the two groups. At week 4, the mean relative regulatory capacity in the experimental group increased to 4.11D, while the mean relative regulatory capacity in the control group was 3.60D. At week 8, the mean relative regulatory capacity in the experimental group significantly increased to 4.12D compared to the value at week 0 (in Figure 17, "#" indicates a p-value less than 0.05), while the mean relative regulatory capacity in the control group was 3.91D. Furthermore, the relative regulatory capacity measured in the experimental and control groups at week 0 was considered as 1, and the fold change in the relative regulatory capacity measured in weeks 4 and 8 was calculated based on this. The relative fold in the experimental group at week 4 was 1.16, and the relative fold in the experimental group at week 8 was also 1.16, as shown in Figure 18. In other words, the experimental group showed an improvement in relative accommodation, indicating a significant improvement in the overall eye relaxation and contraction accommodation ability of the subjects in the experimental group. The relative fold increase in the control group was 1.03 at week 4 and 1.11 at week 8. This means that the control group did not show significant improvement in overall eye relaxation and contraction accommodation ability after 4 weeks of placebo administration.
[0119] Furthermore, relaxing the ciliary muscle can reduce eye strain, swelling, and even the likelihood of headaches. Therefore, taking black tomato extract can improve the eye's accommodative power, thereby enhancing the ability to relax the ciliary muscle, thus alleviating eye strain and swelling, and preventing headaches caused by excessive ciliary muscle tension.
[0120] Example 2-4: Dry Eye Syndrome Assessment
[0121] Testing method: Subjects were asked to complete the Ocular Surface Disease Index (OSDI) questionnaire before starting medication (week 0), at weeks 2, 4, 6, and 8. The questionnaire is shown in Table 1. The test consists of 12 questions, each a single-choice question, with each option corresponding to a different score (indicated in parentheses in the table).
[0122] Table 1
[0123] The assessment method for dry eye syndrome is as follows: OSDI score = total score × 25 / total number of responses. An OSDI score of 0 to 12 indicates "no dry eye syndrome, normal"; an OSDI score of 13 to 22 indicates "mild dry eye syndrome"; an OSDI score of 23 to 32 indicates "moderate dry eye syndrome"; and an OSDI score of 33 to 100 indicates "severe dry eye syndrome". The results are shown in Figure 19. In the graph, "#" represents a p-value less than 0.05. "#" indicates the difference compared to the data from week 0 (differences within the same group at different time points).
[0124] Please refer to Figure 19. The OSDI score calculated by the subjects at week 0 was considered as 100% to represent the severity of dry eye-related symptoms. The severity in the experimental group decreased to 74.6% at week 2, significantly decreased to 66.3% at week 4, significantly decreased to 65.3% at week 6, and significantly decreased to 59.5% at week 8. This indicates that taking black tomato extract for two weeks can significantly reduce the severity of dry eye-related symptoms by 25.4%, effectively relieving dry eyes, reducing photophobia, improving blurred vision, and reducing the feeling of foreign objects in the eye, thus alleviating symptoms of eye fatigue and dryness, improving eye comfort, enhancing vision, and reducing eye discomfort.
[0125] As can be seen from the above, black tomato extract has the ability to relieve at least one type of dry and uncomfortable eye condition, such as eye soreness, photophobia, blurred vision, and foreign body sensation in the eye.
[0126] In summary, the black tomato extract according to any embodiment of the present invention has multiple abilities to relieve eye discomfort and improve visual function: the black tomato extract can relieve eye soreness, reduce photophobia, improve blurred vision, reduce foreign body sensation in the eye, and improve individual visual function, such as visual acuity, eye accommodation, visual contrast sensitivity, and retinal light adaptation.
[0127] Although the technical content of the present invention has been disclosed above with reference to preferred embodiments, it is not intended to limit the present invention. Any modifications and refinements made by those skilled in the art without departing from the spirit of the present invention should be included within the scope of the present invention. Therefore, the scope of protection of the present invention shall be determined by the scope of the appended claims.
[0128] Industrial application
[0129] The use of a black tomato extract in the preparation of a composition for relieving dry eye discomfort and / or improving visual function in an individual. The composition includes a black tomato extract, which is extracted from a black tomato (Solanum lycopersicum).
Claims
1. Use of a black tomato extract for the preparation of a composition for alleviating ocular dryness discomfort in an individual, characterized in that, The composition includes a black tomato extract, which is obtained from black tomatoes (Solanum lycopersicum).
2. Use according to claim 1, characterized in that, The dry and uncomfortable eyes are described as eye pain, photophobia, blurred vision, a foreign body sensation in the eye, or a combination thereof.
3. Use of a black tomato extract for the preparation of a composition for improving visual function in an individual, characterized in that, The composition includes a black tomato extract, which is obtained from black tomatoes (Solanum lycopersicum).
4. Use according to claim 3, characterized in that, The improvement of the individual's visual function is to enhance the individual's visual acuity, eye accommodation, visual contrast sensitivity, retinal light adaptation, or a combination thereof.
5. Use according to claim 4, characterized in that, Improving the individual's vision means improving near vision.
6. Use according to claim 4, characterized in that, Improving the individual's vision means improving distance vision.
7. Use according to claim 4, characterized in that, Improving the individual's eye accommodation ability means enhancing the individual's ability to contract and relax the ciliary muscle.
8. Use according to claim 4, characterized in that, Improving the visual contrast sensitivity of the individuals refers to improving their visual contrast sensitivity in dimly lit environments.
